"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

When prescribing glucagon-like peptide 1 (GLP-1) medications, many physicians prefer tirzepatide over the more well-known semaglutide due to its superior efficacy in weight loss and A1c reduction.

But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

The study examined GLP-1 drugs, which include semaglutide and tirzepatide. Semaglutide is a key ingredient in Ozempic and Wegovy. Wegovy and Ozempic have also been found to reduce other risks ...

Online weight loss prescriptions are easier to get than ever before, but you should ensure you’re getting appropriate care rather than just a prescription, says Holly Lofton, M.D., an obesity ...

The South African Health Products Regulatory Authority (Sahpra) has urged people to avoid buying fake versions of diabetes treatments Ozempic and Mounjaro, for weight loss. Diabetes drugs such as ...

Semaglutide and a similar GLP-1 drug, tirzepatide (Mounjaro/Zepbound), had been on the FDA’s shortages list since 2022, as ...